The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Resource utilization among neuroendocrine tumor patients in the United States.
Roman Casciano
Consultant or Advisory Role - Novartis
Maruit Chulikavit
Consultant or Advisory Role - Novartis
Rohan Parikh
Consultant or Advisory Role - Novartis
Lee Stern
Consultant or Advisory Role - Novartis
Zhimei Liu
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Xufang Wang
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Jonathan R. Strosberg
Consultant or Advisory Role - Novartis
Research Funding - Novartis